The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up

the ABLE-UK investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalHealth Technology Assessment
Issue number62
Publication statusPublished - 31 Oct 2017

Cite this